MS-STAT2 (@MsStat2) header
MS-STAT2 (@MsStat2) profile picture

Updates and insight on the MS-STAT2 study from the team at UCL. A phase 3 clinical trial of high dose simvastatin for secondary progressive multiple sclerosis

London, England
Joined April 2019
The European Academy of Neurology 2023 conference! Let's talk #MS #BigData #Biomarkers #SmoulderingMS #clinicaltrials #PIRA and much more!
3
252
#MSAwarenessWeek - how does MS make you feel? Does it affect you personally, or someone you know? Our amazing colleague Dr Alessia Bianchi @alessia_bia completing the London marathon to fundraiser for the @mssocietyuk! If you'd like please donate via: 2023tcslondonmarathon.enthus…
1
1
14
742
Fantastic to have team MS-STAT2 at #MSFrontiers! Congratulations to ⁦⁦@mssocietyuk⁩ for a brilliant conference in beautiful Swansea!
1
1
20
Rachael Hunter presenting fascinating but quite shocking data on the impact of #SPMS on employment and quality of life for people in MS-STAT2. This is why we need treatments!
7
21
Fantastic to have ⁦@judy_beveridge⁩ talking about patient and public involvement in MS-STAT2 😊😊
1
1
6
Almost 6000 patient visits in MS-STAT2 so far 😱👏👏
1
7
Jeremy Chataway introducing hugely inspirational talk from ⁦@CarolineWyatt⁩ at MS-STAT2 investigators meeting on the hope that participating in clinical trials can bring 👏👏👏😊😊
1
18
Changes in MS DMT initiations across NHS England during the start of the #COVID19 pandemic: jnnp.bmj.com/content/early/2… @DrWBRO @mssocietyuk
2
6
Replying to @griffax09
New lesions is enough. The time window during which they have to have appeared is debated.
1
@JanisWinehouse I think you were one of the first!
1
5